Chargement des cours...
Prévisions
| Acheter |
1 |
| Conserver |
0 |
| Vendre |
0 |
Actualités Accéder au fil d'actualités
The Cannabist Company sells Virginia business to Curaleaf for $110 million
The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Plus sur de.investing.com
Cannabist Company reports revenue decline and falling EBITDA in Q3 2025
Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Plus sur de.investing.com
Cannabist Company reports revenue decline and share price loss due to restructuring
Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | sept. 2025 | |
|---|---|---|
| Chiffre d'affaires | 68,10M | - |
| Bénéfice brut | 19,52M | - |
| Bénéfice net | −12,15M | - |
| EBITDA | 6,65M | - |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 12,42M€ |
Nombre d'actions | 497,46M |
Plus haut/bas sur 52 semaines | 0,14€ - 0,0172€ |
| Dividendes | Non |
Bêta | 1,05 |
Ratio P/E | −0,11 |
Ratio PEG | 0,00 |
Ratio P/B | −0,10 |
Ratio P/S | 0,06 |
Profil de l'entreprise
The Cannabist Company Holdings Inc. beschäftigt sich mit dem Anbau, der Herstellung und der Bereitstellung von Cannabisprodukten und damit verbundenen Dienstleistungen in den Vereinigten Staaten und international. Das Unternehmen bietet übergreifende Blüten, Esswaren, Öle und Tabletten unter den Markennamen Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press und Amber an. Es verfügt über Lizenzen in 17 Gerichtsbarkeiten in den Vereinigten Staaten. Das Unternehmen war früher als Columbia Care Inc. bekannt und änderte im September 2023 seinen Namen in The Cannabist Company Holdings Inc. Das Unternehmen wurde im Jahr 2012 gegründet und hat seinen Hauptsitz in New York, New York.
| Nom | Cannabist Co. Holdings Aktie |
| PDG | Christopher Marr |
| Siège social | Malvern,
pa États-Unis |
| Site web | |
| Introduction en bourse | 29/04/2019 |
| Employés | 2.829 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
Neo | CBST.NE |
Pnk | CBSTF |
Frankfurt | VW5.F |
Düsseldorf | VW5.DU |
München | VW5.MU |
Découvrir des actifs
Les actionnaires de Cannabist Co. Holdings Aktie investissent également dans les actifs suivants

